ABIONYX Pharma SA (EPA:ABNX)

ABIONYX Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.38	3.24	4.1	4.05	7.94	9.15
Cash & Short-Term Investments	3.38	3.24	4.1	4.05	7.94	9.15
Cash Growth	-36.37%	-21.17%	1.43%	-49.01%	-13.32%	9.88%
Accounts Receivable	0.57	0.99	0.91	1.3	1.33	-
Other Receivables	1.12	1.3	1.58	1.76	3.29	0.84
Receivables	1.69	2.3	2.5	3.05	4.62	0.84
Inventory	0.21	0.21	0.22	0.15	0.18	-
Prepaid Expenses	0.18	0.12	0.07	0.33	0.28	0.04
Total Current Assets	5.45	5.86	6.89	7.57	13.01	10.03
Property, Plant & Equipment	1.93	1.98	2.22	2.56	3.07	0.12
Long-Term Investments	0.08	0.08	0.08	0.08	0.08	-
Goodwill	5.38	5.38	5.38	5.38	5.38	-
Other Intangible Assets	0.07	0.08	0.08	0.08	0.08	0.05
Other Long-Term Assets	0.11	0.11	0.14	0.12	0.19	0.1
Total Assets	13.07	13.54	14.83	15.82	21.83	10.29
Accounts Payable	1.26	1.63	1.44	1.85	2.71	2.41
Accrued Expenses	1.19	0.93	1.03	1.03	1.51	0.23
Short-Term Debt	-	-	0	0	0.17	-
Current Portion of Long-Term Debt	0.52	0.5	0.5	0.49	0.49	-
Current Portion of Leases	0.33	0.34	0.31	0.38	0.4	0.02
Current Unearned Revenue	0.56	0.29	0.59	0.38	0.43	0
Other Current Liabilities	0.02	0.01	0.06	0.96	1.04	0.93
Total Current Liabilities	3.88	3.71	3.93	5.09	6.75	3.6
Long-Term Debt	2.11	0.61	1.1	1.42	1.65	-
Long-Term Leases	1.16	1.3	1.47	1.73	2.25	-
Pension & Post-Retirement Benefits	0.41	0.41	0.41	0.42	0.5	0.06
Total Liabilities	7.56	6.03	6.91	8.65	11.16	3.66
Common Stock	1.75	1.75	1.62	1.42	1.4	1.23
Additional Paid-In Capital	4.65	8.61	12.57	8.6	179.21	170.32
Retained Earnings	-2.31	-4.38	-3.52	-4.21	-5.82	-1.89
Treasury Stock	-0.26	-0.25	-0.19	-	-	-
Comprehensive Income & Other	1.67	1.8	-2.56	1.36	-164.11	-163.04
Shareholders' Equity	5.5	7.52	7.92	7.17	10.68	6.63
Total Liabilities & Equity	13.07	13.54	14.83	15.82	21.83	10.29
Total Debt	4.12	2.76	3.39	4.01	4.96	0.02
Net Cash (Debt)	-0.74	0.48	0.71	0.03	2.98	9.13
Net Cash Growth	-	-33.05%	2063.64%	-98.89%	-67.39%	27.73%
Net Cash Per Share	-0.02	0.01	0.02	0.00	0.12	0.39
Filing Date Shares Outstanding	34.93	34.68	32.21	28.1	27.7	24.4
Total Common Shares Outstanding	34.93	34.68	32.21	28.1	27.7	24.4
Working Capital	1.57	2.15	2.96	2.48	6.26	6.44
Book Value Per Share	0.16	0.22	0.25	0.26	0.39	0.27
Tangible Book Value	0.05	2.06	2.47	1.72	5.22	6.58
Tangible Book Value Per Share	0.00	0.06	0.08	0.06	0.19	0.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.